UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction ...

HCA Healthcare Inc. (NYSE:HCA) Q2 2023 Earnings Call Transcript July 27, 2023 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - CEO and Director Bill Rutherford - Executive VP and CFO Conference Call Participants A.J. Rice - Credit Suisse Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Gary Taylor - Cowen Justin Lake - Wolfe Research Phil Chickering - Detroit Bank Ann Hynes - Mizuho Group Kevin Fischbeck - Bank of America Brian Tanquilut - Jeffer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction ...

HCA Healthcare, Inc. (NYSE:HCA) Q1 2023 Earnings Conference Call April 21, 2023 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Whit Mayo - SVB Securities Justin Lake - Wolfe Research Ben Hendrix - RBC Capital Markets Gary Taylor - Cowen Pito Chickering - Deutsche Bank Joshua Raskin - Nephron Research Brian Tanquilut - Jefferies Andrew Mok ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3865930 (State or Other Jurisdiction of I ...

HCA Healthcare, Inc. (NYSE:HCA) Q4 2022 Earnings Conference Call January 27, 2023 10:00 AM ET Company Participants Frank Morgan - Vice President, Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Gary Taylor - Cowen Ben Hendrix - RBC Capital Markets Whit Mayo - SVB Securities Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Ann Hynes - Mizuho Securities Brian Ta ...

1 Investor Update Q3 2022 Forward looking statements and non-GAAP financial measures 2 This presentation contains certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows , costs and ...

1 Investor Update Q3 2022 Forward looking statements and non-GAAP financial measures 2 This presentation contains certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows , costs and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdic ...

HCA Healthcare, Inc. (NYSE:HCA) Q3 2022 Results Conference Call October 21, 2022 9:00 AM ET Company Participants Frank Morgan - VP, IR Sam Hazen - CEO Bill Rutherford - CFO Conference Call Participants A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Ann Hynes - Mizuho Securities Justin Lake - Wolfe Research Gary Taylor - Cowen Andrew Mok - UBS Whit Mayo - SVB Securities Ben Hendrix - RBC Capital Markets Lance Wilkes - Bernstein Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Scott Fi ...